Press Release

PleoPharma, Inc.

Feb 13

FDA GRANTS FAST TRACK DESIGNATION TO PLEOPHARMA, INC's INVESTIGATIONAL NEW DRUG, PP-01, FOR THE MITIGATION OF CANNABIS WITHDRAWAL SYMPTOMS IN PATIENTS WITH CANNABIS USE DISORDER:

A POTENTIAL FIRST IN TREATMENT Fast Track Designation highlights the potential of PP-01 to address a serious and unmet need for patients...

PleoPharma, Inc.

Nov 18, 2024

PHOENIXVILLE, Pa., Nov. 18, 2024 /PRNewswire/ -- PleoPharma, Inc., a privately held company focused on cannabis-related health issues

PleoPharma, Inc.

Oct 7, 2024

PHOENIXVILLE, Pa., Oct. 7, 2024 PleoPharma, Inc., a privately held company focused on Cannabis-related health issues, announced today that

PleoPharma, Inc.

Sep 19, 2024

PHOENIXVILLE, Pa., Sept. 19, 2024 -- PleoPharma, Inc., a privately held company focused on cannabis related health issues, announced today..

PleoPharma, Inc.

Sep 5, 2024

PHOENIXVILLE, Pa., Sept. 5, 2024 -- PleoPharma, Inc., a privately held company focused on cannabis related health issues, announced today...